Page 1 | Search Results | Diabetes Care | American Diabetes Association

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Erratum. Profibrotic Circulating Proteins and Risk of Early Progressive Renal Decline in Patients With Type 2 Diabetes With and Without Albuminuria. Diabetes Care 2020;43: 2760–2767

Katsuhito Ihara, Jan Skupien, Hiroki Kobayashi, Zaipul I. Md Dom, Jonathan M. Wilson, Kristina O’Neil, Hannah S. Badger, Lenden M. Bowsman, Eiichiro Satake, Matthew D. Breyer, Kevin L. Duffin, Andrzej S. Krolewski

Diabetes Care 2021;44(2):631

https://doi.org/10.2337/dc21-er02

Published: 17 December 2020

View article titled, Erratum. Profibrotic Circulating Proteins and Risk of Early Progressive Renal Decline in Patients With Type 2 Diabetes With and Without Albuminuria. Diabetes Care 2020;43: 2760–2767

Journal Articles

Profibrotic Circulating Proteins and Risk of Early Progressive Renal Decline in Patients With Type 2 Diabetes With and Without Albuminuria

Diabetes Care 2020;43(11):2760–2767

https://doi.org/10.2337/dc20-0630

Published: 04 September 2020

View article titled, Profibrotic Circulating Proteins and Risk of Early Progressive Renal Decline in Patients With Type 2 Diabetes With and Without Albuminuria

Journal Articles

Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy

Diabetes Care 2019;42(1):93–101

https://doi.org/10.2337/dc18-1369

Published: 19 November 2018

View article titled, Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy

Journal Articles

Patterns of Estimated Glomerular Filtration Rate Decline Leading to End-Stage Renal Disease in Type 1 Diabetes

Jan Skupien, James H. Warram, Adam M. Smiles, Robert C. Stanton, Andrzej S. Krolewski

Diabetes Care 2016;39(12):2262–2269

https://doi.org/10.2337/dc16-0950

Published: 19 September 2016

View article titled, Patterns of Estimated Glomerular Filtration Rate Decline Leading to End-Stage Renal Disease in Type 1 Diabetes

Journal Articles

Genetic Predictors of Cardiovascular Mortality During Intensive Glycemic Control in Type 2 Diabetes: Findings From the ACCORD Clinical Trial

Hetal S. Shah, He Gao, Mario Luca Morieri, Jan Skupien, Skylar Marvel, Guillaume Paré, Gaia C. Mannino, Patinut Buranasupkajorn, Christine Mendonca, Timothy Hastings, Santica M. Marcovina, Ronald J. Sigal, Hertzel C. Gerstein, Michael J. Wagner, Alison A. Motsinger-Reif, John B. Buse, Peter Kraft, Josyf C. Mychaleckyj, Alessandro Doria

Diabetes Care 2016;39(11):1915–1924

https://doi.org/10.2337/dc16-0285

Published: 15 August 2016

View article titled, Genetic Predictors of Cardiovascular Mortality During Intensive Glycemic Control in Type 2 Diabetes: Findings From the ACCORD Clinical Trial

Includes: Supplementary data

Journal Articles

Synergism Between Circulating Tumor Necrosis Factor Receptor 2 and HbA_1c in Determining Renal Decline During 5–18 Years of Follow-up in Patients With Type 1 Diabetes and Proteinuria

Jan Skupien, James H. Warram, Monika A. Niewczas, Tomohito Gohda, Maciej Malecki, Josyf C. Mychaleckyj, Andrzej T. Galecki, Andrzej S. Krolewski

Diabetes Care 2014;37(9):2601–2608

https://doi.org/10.2337/dc13-1983

Published: 07 August 2014

View article titled, Synergism Between Circulating Tumor Necrosis Factor Receptor 2 and HbA1c in Determining Renal Decline During 5–18 Years of Follow-up in Patients With Type 1 Diabetes and Proteinuria

Includes: Supplementary data

Journal Articles

Early Progressive Renal Decline Precedes the Onset of Microalbuminuria and Its Progression to Macroalbuminuria

Andrzej S. Krolewski, Monika A. Niewczas, Jan Skupien, Tomhito Gohda, Adam Smiles, Jon H. Eckfeldt, Alessandro Doria, James H. Warram

Diabetes Care 2014;37(1):226–234

https://doi.org/10.2337/dc13-0985

Published: 11 December 2013

View article titled, Early Progressive Renal Decline Precedes the Onset of Microalbuminuria and Its Progression to Macroalbuminuria

Journal Articles

Postpregnancy Glycemic Control and Weight Changes in Type 1 Diabetic Women

Katarzyna Cyganek, MD, Alicja Hebda-Szydlo, MD, Jan Skupien, MD, Izabela Janas, MD, Joanna Walczyk, MD, Anna Lipowska, MD, Sebastian Borys, MD, Maciej T. Malecki, MD

Diabetes Care 2013;36(5):1083–1087

https://doi.org/10.2337/dc12-1340

Published: 13 April 2013

View article titled, Postpregnancy Glycemic Control and Weight Changes in Type 1 Diabetic Women

Journal Articles

Serum Concentration of Cystatin C and Risk of End-Stage Renal Disease in Diabetes

Andrzej S. Krolewski, MD, James H. Warram, MD, Carol Forsblom, DMSC, Adam M. Smiles, MS, Lena Thorn, MD, Jan Skupien, MD, Valma Harjutsalo, PHD, Robert Stanton, MD, John H. Eckfeldt, MD, Lesley A. Inker, MD, Per-Henrik Groop, MD

Diabetes Care 2012;35(11):2311–2316

https://doi.org/10.2337/dc11-2220

Published: 13 October 2012

View article titled, Serum Concentration of Cystatin C and Risk of End-Stage Renal Disease in Diabetes

Includes: Supplementary data

Journal Articles

Clinical Application of 1,5-Anhydroglucitol Measurements in Patients with Hepatocyte Nuclear Factor-1α Maturity-Onset Diabetes of the Young

Jan Skupien, MD, PHD, Sylwia Gorczynska-Kosiorz, PHD, Tomasz Klupa, MD, PHD, Krzysztof Wanic, MD, PHD, Eric A. Button, MS, MBA, Jacek Sieradzki, MD, PHD, Maciej T. Malecki, MD, PHD

Diabetes Care 2008;31(8):1496–1501

https://doi.org/10.2337/dc07-2334

Published: 01 August 2008

View article titled, Clinical Application of 1,5-Anhydroglucitol Measurements in Patients with Hepatocyte Nuclear Factor-1α Maturity-Onset Diabetes of the Young

Journal Articles

Islet-Specific Antibody Seroconversion in Patients With Long Duration of Permanent Neonatal Diabetes Caused by Mutations in the KCNJ11 Gene

Agnieszka Gach, MD, Krystyna Wyka, PHD, Maciej T. Malecki, MD, PHD, Anna Noczynska, MD, PHD, Jan Skupien, MD, Joanna Nazim, MD, PHD, Mieczyslaw Szalecki, MD, PHD, Jerzy Bodalski, MD, PHD, Jacek Sieradzki, MD, PHD, Wojciech Mlynarski, MD, PHD

Diabetes Care 2007;30(8):2080–2082

https://doi.org/10.2337/dc06-2440

Published: 01 August 2007

View article titled, Islet-Specific Antibody Seroconversion in Patients With Long Duration of Permanent Neonatal Diabetes Caused by Mutations in the KCNJ11 Gene

Includes: Supplementary data

Journal Articles

Transfer to Sulphonylurea Therapy in Adult Subjects With Permanent Neonatal Diabetes Due to KCNJ11-Activating Mutations: Evidence for improvement in insulin sensitivity

Maciej T. Malecki, MD, PHD, Jan Skupien, MD, Tomasz Klupa, MD, PHD, Krzysztof Wanic, MD, PHD, Wojciech Mlynarski, MD, PHD, Agnieszka Gach, MD, Iwona Solecka, MD, Jacek Sieradzki, MD, PHD

Diabetes Care 2007;30(1):147–149

https://doi.org/10.2337/dc06-1628

Published: 01 January 2007

View article titled, Transfer to Sulphonylurea Therapy in Adult Subjects With Permanent Neonatal Diabetes Due to KCNJ11-Activating Mutations: <subtitle>Evidence for improvement in insulin sensitivity</subtitle>

Journal Articles

Renal Malformations May Be Linked to Mutations in the Hepatocyte Nuclear Factor-1α (MODY3) Gene

Maciej T. Malecki, MD, PHD, Jan Skupien, MD, Sylwia Gorczynska-Kosiorz, PHD, Tomasz Klupa, MD, PHD, Joanna Nazim, MD, PHD, Dariusz K. Moczulski, MD, PHD, Jacek Sieradzki, MD, PHD

Diabetes Care 2005;28(11):2774–2776

https://doi.org/10.2337/diacare.28.11.2774

Published: 01 November 2005

View article titled, Renal Malformations May Be Linked to Mutations in the Hepatocyte Nuclear Factor-1α (MODY3) Gene

NARROW

Erratum. Profibrotic Circulating Proteins and Risk of Early Progressive Renal Decline in Patients With Type 2 Diabetes With and Without Albuminuria. Diabetes Care 2020;43: 2760–2767

Profibrotic Circulating Proteins and Risk of Early Progressive Renal Decline in Patients With Type 2 Diabetes With and Without Albuminuria

Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy

Patterns of Estimated Glomerular Filtration Rate Decline Leading to End-Stage Renal Disease in Type 1 Diabetes

Genetic Predictors of Cardiovascular Mortality During Intensive Glycemic Control in Type 2 Diabetes: Findings From the ACCORD Clinical Trial

Synergism Between Circulating Tumor Necrosis Factor Receptor 2 and HbA_1c in Determining Renal Decline During 5–18 Years of Follow-up in Patients With Type 1 Diabetes and Proteinuria

Early Progressive Renal Decline Precedes the Onset of Microalbuminuria and Its Progression to Macroalbuminuria

Postpregnancy Glycemic Control and Weight Changes in Type 1 Diabetic Women

Serum Concentration of Cystatin C and Risk of End-Stage Renal Disease in Diabetes

Clinical Application of 1,5-Anhydroglucitol Measurements in Patients with Hepatocyte Nuclear Factor-1α Maturity-Onset Diabetes of the Young

Islet-Specific Antibody Seroconversion in Patients With Long Duration of Permanent Neonatal Diabetes Caused by Mutations in the KCNJ11 Gene

Transfer to Sulphonylurea Therapy in Adult Subjects With Permanent Neonatal Diabetes Due to KCNJ11-Activating Mutations: Evidence for improvement in insulin sensitivity

Renal Malformations May Be Linked to Mutations in the Hepatocyte Nuclear Factor-1α (MODY3) Gene

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only